Lo AC, Liu A, Liu Q, Yasui Y, Castellino SM, Kelly KM, Hererra AF, Friedberg JW, Friedman DL, Schwartz CL, Pei Q, Kessel S, Bergeron-Gravel S, Dama H, Roberts K, Constine LS, Hodgson DC. Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children. JAMA Netw Open. 2024 Jan 02;7(1):e2351062 PMID: 38241048 PMCID: PMC10799264 01/19/2024
Phadnis S, Wang X, Daw NC, Herzog CE, Subbiah IM, Zaky W, Gouda MA, Morani AC, Amini B, Harrison DJ, Piha-Paul SA, Meric-Bernstam F, Gorlick R, Schwartz CL, Subbiah V. Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study. ESMO Open. 2023 Dec;8(6):101609 PMID: 37879233 PMCID: PMC10774869 SCOPUS ID: 2-s2.0-85174677881 10/26/2023
Valencia MC, Hang L, Schmidt D, Nichols J, Zhang J, Yan K, Gonzalez A, Schwartz CL, Phelan R. Next Steps: Survivor Healthcare Passport - A Novel Form of Survivorship Care Plan in the Pediatric Population. J Pediatr Hematol Oncol. 2023 Jul 01;45(5):e573-e577 PMID: 36898042 SCOPUS ID: 2-s2.0-85163834080 03/11/2023
Chow EJ, Aggarwal S, Doody DR, Aplenc R, Armenian SH, Baker KS, Bhatia S, Blythe N, Colan SD, Constine LS, Freyer DR, Kopp LM, Laverdière C, Leisenring WM, Sasaki N, Vrooman LM, Asselin BL, Schwartz CL, Lipshultz SE. Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer. J Clin Oncol. 2023 Apr 20;41(12):2248-2257 PMID: 36669148 PMCID: PMC10448941 SCOPUS ID: 2-s2.0-85152621880 01/21/2023
Werk RS, Koyama T, Sun L, Wolden S, Kelly KM, Constine LS, Schwartz CL, Friedman DL. Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children\'s Oncology Group AHOD0031. J Adolesc Young Adult Oncol. 2023 Jun;12(3):359-365 PMID: 36094417 PMCID: PMC10282797 SCOPUS ID: 2-s2.0-85149947480 09/13/2022
Parekh A, Keller FG, McCarten KM, Kessel S, Cho S, Pei Q, Wu Y, Castellino SM, Constine LS, Schwartz CL, Hodgson D, Kelly KM, Hoppe BS. Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis. Blood. 2022 Sep 08;140(10):1086-1093 PMID: 35763667 PMCID: PMC9461469 SCOPUS ID: 2-s2.0-85137371565 06/29/2022
Kahn JM, Pei Q, Friedman DL, Kaplan J, Keller FG, Hodgson D, Wu Y, Appel BE, Bhatia S, Henderson TO, Schwartz CL, Kelly KM, Castellino SM. Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children\'s oncology group trials. Lancet Haematol. 2022 Jan;9(1):e49-e57 PMID: 34971582 PMCID: PMC8815096 SCOPUS ID: 2-s2.0-85121687510 01/01/2022
Lipshultz ER, Chow EJ, Doody DR, Armenian SH, Asselin BL, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Schwartz CL, Lipshultz SE, Vrooman LM. Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children\'s Oncology Group. Cancer Epidemiol Biomarkers Prev. 2022 Mar 01;31(3):536-542 PMID: 34810210 PMCID: PMC9067064 SCOPUS ID: 2-s2.0-85125861487 11/24/2021
Parikh RR, Kelly KM, Hodgson DC, Hoppe BS, McCarten KM, Karolczuk K, Pei Q, Wu Y, Cho SY, Schwartz C, Cole PD, Roberts K. Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children\'s Oncology Group. Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):890-900 PMID: 34767937 PMCID: PMC9038118 SCOPUS ID: 2-s2.0-85121755582 11/13/2021
Johnston RL, Mottok A, Chan FC, Jiang A, Diepstra A, Visser L, Telenius A, Gascoyne RD, Friedman DL, Schwartz CL, Kelly KM, Scott DW, Horton TM, Steidl C. A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma. Blood. 2022 Feb 10;139(6):889-893 PMID: 34662378 PMCID: PMC8832480 SCOPUS ID: 2-s2.0-85124227160 10/19/2021